GLPwatch
Trials (2095)
Page 7 of 35.
- Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes
- A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
- The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
- Tirzepatide vs Liraglutide in Bone
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- Semaglutide for Helping Opioid Recovery
- Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
- Glucagon-like Peptide (GLP) Utilization and Safety
- Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
- Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
- Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
- Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
- Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
- Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
- Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects
- Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
- Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
- The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
- Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
- Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
- AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
- The Effect of Liraglutide on the GIT
- Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
- A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
- Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
- Role of Exenatide in NASH-a Pilot Study
- A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
- A Study of BGM0504 in Participants With Obesity
- A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
- Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy
- Comprehensive Clinical Evaluation Study of GLP-1RA
- Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
- Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
- The Effect of a Liraglutide on IVF in Obese PCOS
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
- GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
- Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
- The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
- A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
- Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
- RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
- Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
- Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
- Effects of GLP-1 on Chronic Heart Failure